Health In Tech, Inc.
Health In Tech, Inc. operates as a cutting-edge insurance technology provider. The company delivers a range of specialized insurance solutions for smaller enterprises, such as value-based pricing strategies, group insurance captives, localized community health plans, and collective association health programs.…
1D
+3.7%
1W
-11.9%
1M
-23.3%
6M
-56.5%
YTD
-59.0%
1Y
-81.0%
2Y
–
5Y
–
10Y
–
Next earnings date
09/11/2026 (in 23 days)
Volatility around earnings
~333% stronger price swings than usual
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 13/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BearishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
PRICE TARGET LOW
US$3.00
CONSENSUS
US$3.50
MEDIAN
US$3.50
PRICE TARGET HIGH
US$4.00
0
STRONG BUY
1
BUY
0
HOLD
0
SELL
0
STRONG SELL
1
TOTAL · Buy
As of: 14/08/2026
P/E
-9.25
P/B
2.09
EV/EBITDA
-7.05
RETURN ON EQUITY
-12.8%
NET MARGIN
-31.2%
DEBT/EQUITY
0.01
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
24.0%
FLOAT SHARES
12,885,943
AVG. DAILY VOLUME (30D)
297,797
Hayes Timothy
Howard William D.
Johnson Tim Donald
Qian LinLin
Hasan Zain Syed
Health In Tech, Inc. is a company in the Technology sector, Software - Application industry, headquartered in United States.
The CEO is Tim Johnson, the company employs around 89 people.
The IPO was on 23/12/2024; the stock trades on NASDAQ under the ticker HIT.
1 analysts rate the stock, the consensus is Buy (as of 14/08/2026).
The average price target is US$3.50, ranging from US$3.00 to US$4.00, with a median of US$3.50.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 09/11/2026.
Around past earnings, price swings were roughly 333% stronger than usual.
No, Health In Tech currently does not pay a dividend.
Comparable stocks include Salesforce, ServiceNow, Uber Technologies, Snowflake, Automatic Data Processing, Datadog, Cadence Design Systems and Adobe.
Clicking "Analyze stock" lets five strategies assess Health In Tech against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.